Home

Research

Alzheimer's Disease

Read time: 3 min

Satellite symposium

New insights into the role of neuroinflammation in Alzheimer’s disease

Evidence supporting the key role of neuroinflammation in Alzheimer’s disease was presented by...

Read time: 3 min

Congress highlights

Highlights in depression research from APA Online 2022

Recent research findings in depression from the poster session at APA Online 2022 covered topics...

Read time: 3 min

Satellite symposium

New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention

New real-world data on the effectiveness, tolerability, and other benefits of migraine prevention...

Read time: 2 min

Congress highlights

Hippocampal N-methyl-D-aspartate receptor hypofunction in first-episode psychosis pathophysiology

Lower N-methyl-D-aspartate receptor availability in the hippocampus compared with other brain...

Read time: 4 min

What biological markers can reveal about depression and antidepressant response

In a symposium entitled ‘Biological Markers in Depression: From Animals to Humans,’...

Alzheimer's Disease

Read time: 2 min

Congress highlights

New more accessible and affordable techniques for identifying people at risk of Alzheimer’s disease

In specialist clinics, cerebrospinal fluid biomarkers for Abeta1-42, Abeta1-40, tTau, and pTau or...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Targeting tau – homing-in on effective therapies in Alzheimer’s disease

Several new and highly promising therapeutics for the management and possible prevention of...

Anxiety, Depression

Read time: 2 min

Satellite symposium

Anxious distress and major depressive disorder: Recognition, assessment and treatment

In an industry-sponsored symposium (Servier Laboratories), titled ‘Anxiety symptoms in...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Netherlands

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country